Provided by Tiger Trade Technology Pte. Ltd.

PROCEPT BioRobotics

17.02
-1.2000-6.59%
Volume:1.60M
Turnover:27.51M
Market Cap:974.80M
PE:-8.74
High:18.46
Open:18.26
Low:16.74
Close:18.22
52wk High:38.11
52wk Low:16.67
Shares:57.27M
Float Shares:54.47M
Volume Ratio:0.91
T/O Rate:2.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9478
EPS(LYR):-1.7207
ROE:-30.24%
ROA:-14.75%
PB:2.87
PE(LYR):-9.89

Loading ...

U.S. Research Roundup-Ametek, Ball Corp, McDonald's

Reuters
·
Aug 05

William Blair downgrades PROCEPT BioRobotics (PRCT) to a Hold

TIPRANKS
·
Aug 05

Procept Biorobotics Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Procept BioRobotics Q2 Net Loss Widens to $26.86 Million; Revenue Rises 19% to $94.5 Million

Reuters
·
Aug 05

Procept BioRobotics Q2 Revenue Beats Estimates on Hydros Demand

Reuters
·
Aug 05

PROCEPT BioRobotics Q2 EPS $(0.47) Misses $(0.46) Estimate, Sales $94.498M Beat $92.893M Estimate

Benzinga Earnings
·
Aug 05

Procept Biorobotics Q2 Revenue USD 94.498 Million Vs. IBES Estimate USD 92.9 Million

Reuters
·
Aug 05

Procept Biorobotics Outlook FY Gross Margin 65%

THOMSON REUTERS
·
Aug 05

Procept Biorobotics Outlook FY Revenue USD 390-410 Million

THOMSON REUTERS
·
Aug 05

Procept Biorobotics Corp - Expects Fy2026 U.S. Procedure Volume of 54,000-56,000, up 25%-29%

THOMSON REUTERS
·
Aug 05

PROCEPT BioRobotics Reports Second Quarter 2026 Financial Results

GlobeNewswire
·
Aug 05

PROCEPT BioRobotics Lawsuit Puts PRCT Investor Losses in Focus After Alleged Handpiece Demand Disclosures

TIPRANKS
·
Jul 31

Earning Preview: PROCEPT BioRobotics Q2 revenue is expected to increase by 21.59%, and institutional views are bullish

Earnings Agent
·
Jul 29

Medical Robotics Firm PROCEPT BioRobotics Faces Class Action Over Hidden Discount Scheme

Deep News
·
Jul 29

Medical Robotics Company PROCEPT BioRobotics Confronts Securities Fraud Lawsuit Over Discount Disclosure Issues

Deep News
·
Jul 29

Procept BioRobotics Coverage Assumed by UBS at Neutral vs Previous Rating of Buy

Dow Jones
·
Jul 29

UBS Downgrades PROCEPT BioRobotics to Neutral From Buy, Cuts Price Target to $20 From $30

MT Newswires Live
·
Jul 28

Shareholder Action Against Surgical Robotics Firm Over Alleged Deceptive Sales Practices

Deep News
·
Jul 27

Analysts’ Opinions Are Mixed on These Healthcare Stocks: TG Therapeutics (TGTX), Protagonist Therapeutics (PTGX) and PROCEPT BioRobotics (PRCT)

TIPRANKS
·
Jul 16

Mobia Medical Names Reza Zadno to Board as Independent Director

Reuters
·
Jul 16